M&A

'The lights are no longer green': Antitrust regulators reassess pharma deals
BioPharma Dive
Thu, 06/10/21 - 11:35 pm
antitrust
M&A
AI-drug discovery biotech Valo Health is going public via a $2.8B SPAC merger
MedCity News
Thu, 06/10/21 - 10:48 am
Valo Health
SPAC
M&A
artificial intelligence
drug discovery
Roivant's data spinout merges with rival in $7B deal
Endpoints
Wed, 06/9/21 - 11:07 am
Roivant
Datavant
M&A
Ciox Health
RWE
data
Medtronic's HeartWare HVAD ending brings questions about $1B acquisition
Medtech Dive
Wed, 06/9/21 - 11:02 am
devices
Medtech
Medtronic
M&A
HeartWare
HVAD pump
Carbon Health buys virtual diabetes clinic firm Steady Health
Pharmaforum
Tue, 06/8/21 - 11:02 am
Carbon Health
digital health
diabetes
M&A
With Illumina Acquisition Pending, GRAIL Presents Multi-Cancer Detection Test
BioSpace
Mon, 06/7/21 - 08:32 pm
ASCO 2021
Grail
Illumina
M&A
diagnostics
clinical trials
cancer
Galleri
Alexion, AstraZeneca executives switch roles amid $39B buyout
BioPharma Dive
Sun, 06/6/21 - 10:33 pm
AstraZeneca
Alexion
M&A
Bayer picks up radiotherapeutics biotech to prop up dwindling sales in prostate cancer program
Fierce Biotech
Thu, 06/3/21 - 10:50 am
Bayer
radiotherapeutics
Noria Therapeutics
M&A
PSMA Therapeutics
Morphosys to buy Constellation in $1.7B deal, aided by unusual funding
BioPharma Dive
Wed, 06/2/21 - 12:10 pm
MorphoSys
M&A
Constellation Pharmaceuticals
GlaxoSmithKline, under activist pressure, gets some relief as Elliott won't push for sale or slash R&D: report
Fierce Pharma
Thu, 05/27/21 - 11:51 pm
GSK
Elliott Management
M&A
Emma Walmsley
hedge funds
Takeda tees up priority review for storied CMV drug from its $62B Shire buyout
Endpoints
Fri, 05/21/21 - 10:51 am
Shire
Takeda
M&A
CMV
maribavir
PerkinElmer inks $155M Immunodiagnostic buyout, continuing deal spree
Medtech Dive
Wed, 05/19/21 - 10:54 am
PerkinElmer
M&A
Immunodiagnostic Systems Holdings
diagnostics
Bristol Myers expands Celgene-era deal with Exscientia, taking its AI R&D engine to the next step
Endpoints
Wed, 05/19/21 - 10:33 am
Bristol Myers Squibb
Exscientia
R&D
Celgene
M&A
artificial intelligence
Bristol Myers hands over $200M upfront, $1.36B in biobucks for Agenus' preclinical TIGIT asset
Fierce Biotech
Tue, 05/18/21 - 11:09 am
Bristol Myers Squibb
Agenus
AGEN1777
M&A
Bristol’s buy moves it to the top of the sales charts
EP Vantage
Tue, 05/18/21 - 10:53 am
Celgene
Bristol-Myers Squibb
M&A
sales reps
Charles River lays out $293M to snap up viral vector specialist Vigene, its 2nd M&A deal this year
Fierce Pharma
Mon, 05/17/21 - 10:43 pm
Charles River Laboratories
M&A
CDMO
Vigene
Compass inks Trigr takeover to land clinical-phase bispecific
Fierce Biotech
Fri, 05/14/21 - 11:04 am
Compass Therapeutics
bispecific antibodies
M&A
Trigr Therapeutics
solid tumors
Alexion Investors Approve Acquisition By AstraZeneca
Yahoo/SmarterAnalyst
Wed, 05/12/21 - 10:46 am
AstraZeneca
Alexion
M&A
Ginkgo lands on Nasdaq via $17.5B SPAC merger, giving it billions to fuel growth
Fierce Biotech
Tue, 05/11/21 - 11:12 am
Ginkgo Bioworks
SPAC
M&A
AbbVie makes a hefty play to boost aesthetics business, paying $550M for non-invasive body sculpting device
Endpoints
Mon, 05/10/21 - 09:37 am
AbbVie
Allergan Aesthetics
M&A
Soliton and Resonic

Pages